Year: 2025
Type: article
Abstract: “...the integration of automation, standardized protocols, evolving regulatory frameworks, and robust scale-up strategies will be critical...” Lauren Coyle, Editor, BioInsights, speaks to Hélène Negre, Pharmaceutical Affairs Director, CELLforCURE, about the manufacturing of ATMPs and how they are undergoing rapid transformations, driven by the need for speed, safety, and scalability. The article shares insights on key challenges in batch release, the importance of cross-functional collaboration, and innovations shaping the future of CGT manufacturing.
Source: Cell and Gene Therapy Insights
Author: Hélène Negre
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7114803157
FWCI:
Cites:
Cited by:
Related to: